Jump Financial, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$45.51 - $65.0 $1.7 Million - $2.42 Million	37,276 New	37,276 $1.71 Million
Q3 2023 Nov 07, 2023	BUY	$45.51 - $65.0 $1.7 Million - $2.42 Million	37,276 New	37,276 $1.71 Million
Q2 2022 Aug 09, 2022	SELL	$29.79 - $42.29 $1.53 Million - $2.17 Million	-51,304 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $516,691 - $820,270	22,504 Added 78.14%	51,304 $1.84 Million
Q4 2021 Feb 10, 2022	BUY	$18.14 - $23.29 $87,072 - $111,792	4,800 Added 20.0%	28,800 $671,000
Q3 2021 Nov 12, 2021	SELL	$17.83 - $21.49 $244,270 - $294,413	-13,700 Reduced 36.34%	24,000 $456,000
Q2 2021 Aug 13, 2021	BUY	$17.11 - $20.92 $645,047 - $788,684	37,700 New	37,700 $760,000

281

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.59B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.